§ COMPARE REGULATORS

NMPA vs COFEPRIS: Medical Device Regulatory Comparison

Compare the medical device registration pathways, classification, and regulatory requirements of NMPA (China) vs COFEPRIS (Mexico).

NMPA

National Medical Products Administration (China)

China

China's NMPA regulates medical devices through CMDE (Center for Medical Device Evaluation) technical reviews. China uses a three-class risk-based system. Foreign manufacturers must appoint a Marketing

CLASSES

Class I, II, III

PATHWAY

NMPA Registration (CMDE review)

KEY FUNCTIONS
  • CMDE technical review
  • MAH (Marketing Authorization Holder) system
  • In-country testing requirements
  • Clinical trial oversight
  • NMPA registration certificates

COFEPRIS

Federal Commission for Protection against Health Risks (Mexico)

Mexico

COFEPRIS regulates medical devices in Mexico under the General Health Law. Mexico uses a three-class system (I, II, III). A sanitary registration (registro sanitario) is required for Class II and III

CLASSES

Class I, II, III

PATHWAY

COFEPRIS sanitary registration

KEY FUNCTIONS
  • Sanitary registration
  • FDA/EU recognition pathway
  • GMP compliance
  • Import permits
  • Vigilance reporting

MedFlux monitors both NMPA and COFEPRIS in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.

COMPARE LIVE DATA FREE →

§ OTHER COMPARISONS